(MedPage Today) — LONG BEACH, Calif. — Low-dose atropine drops showed potential as a noninvasive alternative for managing vitreous floaters, a small retrospective study suggested.
A majority of patients who completed 7 days of treatment (n…
Source link : https://www.medpagetoday.com/meetingcoverage/asrs/116808
Author :
Publish date : 2025-08-03 20:24:00
Copyright for syndicated content belongs to the linked Source.
